Publication: Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury
Issued Date
2021-01-01
Resource Type
ISSN
22221751
Other identifier(s)
2-s2.0-85115277909
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Emerging Microbes and Infections. Vol.10, No.1 (2021), 1862-1872
Suggested Citation
Wanvisa Udomsinprasert, Wanchaloem Sakuntasri, Jiraphun Jittikoon, Usa Chaikledkaew, Sittisak Honsawek, Wasun Chantratita, Sukanya Wattanapokayakit, Surakameth Mahasirimongkol Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury. Emerging Microbes and Infections. Vol.10, No.1 (2021), 1862-1872. doi:10.1080/22221751.2021.1976079 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77344
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury
Other Contributor(s)
Abstract
Despite being highly effective, anti-tuberculosis (TB) drugs often induce adverse liver injury, anti-TB drug-induced liver injury (ATDILI), leading to treatment failure given no sensitive and selective ATDILI markers. Herein, we conducted a case–control association study to determine whether global DNA methylation of Alu and LINE-1 transposable elements responsible for genomic stability and transcriptional regulation was correlated with clinical parameters indicating ATDILI in TB patients and might serve as an ATDILI biomarker. Alu and LINE-1 methylation levels in blood leukocyte of 130 TB patients (80 ATDILI cases and 50 non-ATDILI cases) and 100 healthy controls were quantified using quantitative combined bisulfite restriction analysis. Both TB patients with and without ATDILI had significantly lower methylation levels of Alu and LINE-1 elements than healthy controls. Compared with non-ATDILI patients, Alu methylation levels were significantly decreased in ATDILI patients, commensurate with LINE-1 methylation analysis. Hypomethylation of Alu and LINE-1 measured within 1–7 days of TB treatment was independently associated with raised levels of serum aminotransferases assessed within 8–60 days of TB treatment. Receiver operating characteristic curve analysis uncovered that Alu and LINE-1 methylation levels were both more sensitive and specific for differentiating ATDILI cases from non-ATDILI cases than serum aminotransferases after starting TB treatment within 1–7 days. Kaplan-Meier analysis displayed a significant association between hypomethylation of Alu and LINE-1 elements and an increased rate of ATDILI occurrence in TB patients. Collectively, global DNA hypomethylation of Alu and LINE-1 elements would reflect ATDILI progression and might serve as novel sensitive and specific ATDILI biomarkers.